Concepedia

Danila Branca

DB

Statistics

Publications

10

Citations

589

H-Index

10

Active since

2008

Affiliations

IRBM Science Park(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Danila Branca is an author at IRBM Science Park specializing in drug discovery, medicinal chemistry, and medicine.

ORCID

Top concepts

Publications per year

2008–2023

10

Publications

10

A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors

Thomas J. Tucker, Mark W. Embrey, Candice Alleyne et al. · Journal of Medicinal Chemistry · 2021 · 140 citations · Full text

Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design

Candice Alleyne, Rupesh P. Amin, Bhavana Bhatt et al. · Journal of Medicinal Chemistry · 2020 · 119 citations · Full text

Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor

Douglas G. Johns, Louis‐Charles Campeau, Puja Banka et al. · Circulation · 2023 · 118 citations · Full text

Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors

Federica Orvieto, Danila Branca, Claudia Giomini et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 55 citations · Full text

, , +5

2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors

Ester Muraglia, Sergio Altamura, Danila Branca et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 53 citations · Full text

, , +10

1–5 of 10